# Osteophil Beta-TCP

> Active: United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/osteophil-beta-tcp-mqv>
- Manufacturer: [Cytophil, Inc.](https://devicerts.com/manufacturers/fda-fei-3007225376) (FDA registration: United States)
- Name in the registry: OSTEOPHIL BETA-TCP
- Device class: Class II (US FDA)
- FDA product code: MQV

## Overview

*AI-generated summary, 2026-10-01. Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data is the record.*

Osteophil Beta-TCP is a porous, synthetic, resorbable bone void filler classified as a bone graft substitute. It is composed of beta-Tricalcium Phosphate (B-TCP) and designed to mimic the structure of human cancellous bone through a multidirectional interconnected porosity. This device is intended for filling bony defects in orthopedic applications, including the extremities, posterolateral spine, and pelvis. Its primary function is to provide structural support and promote bone regeneration in surgical sites.

The device is supplied as granules in sizes ranging from 1 mm to 4 mm and is implanted directly by surgeons into the target defect site. Osteophil Beta-TCP is a single-use, non-sterile product, as indicated by its FDA 510(k) clearance (K102937) under product code MQV. It is regulated as a Class II medical device under the Orthopedic advisory committee and is intended for use in orthopedic procedures. Storage and handling must comply with standard medical device protocols for bone graft substitutes.

## Registrations and authorizations

- **510(k)** · FDA 510(k) · United States · K102937 · decision 2010-12-27 · decision SESE · status: Active

## Recalls

No recall on record.

## Identifiers

- 510(k) Number: K102937 [FDA 510(k)]
- FDA product code: MQV [FDA 510(k)]

## Classification

- Device class: Class II [FDA 510(k)]
- Regulation: 21 CFR Part 888.3045 [FDA 510(k)]
- Advisory committee: Orthopedic [FDA 510(k)]
- FDA decision: SESE [FDA 510(k)]

## Source and citation

- Cite as: Osteophil Beta-TCP, Cytophil, Inc. deviCERTS medical device catalogue. https://devicerts.com/devices/osteophil-beta-tcp-mqv (data as of 2026-11-18).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/)
- Registry records last synced: 2026-10-22
- Statuses computed as of: 2026-11-18
- JSON: <https://devicerts.com/devices/osteophil-beta-tcp-mqv.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/osteophil-beta-tcp-mqv
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
